Physiological functions and pharmacological and toxicological effects of p-octopamine

Drug and Chemical Toxicology

Volumn 38, Issue 1, 2015, Pages 106-112

  Stohs, Sidney J ^a,b  

^a CREIGHTON UNIVERSITY MEDICAL CENTER   (United States)

^b Kitsto Consulting LLC ^*  (United States)

Author keywords

Adrenergic receptors; biomarker; metabolism; norsynephrine; prohibited substance; trace amines; weight loss

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR; BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; BETA 3 ADRENERGIC RECEPTOR; OCTOPAMINE; NORSYNEPHRINE RECEPTOR; PROTEIN BINDING; RECEPTOR;

BRAIN TISSUE; DRUG DISTRIBUTION; DRUG MECHANISM; DRUG METABOLISM; DRUG SAFETY; HUMAN; LIPOLYSIS; MEDICINAL CHEMISTRY; NERVOUS TISSUE; NONHUMAN; RECEPTOR BINDING; REVIEW; WEIGHT REDUCTION; ANIMAL; BODY WEIGHT; CHEMICAL STRUCTURE; DRUG EFFECTS; HYPOTENSION; ISOLATION AND PURIFICATION; METABOLISM; PHYSIOLOGY; STEREOISOMERISM;

ANIMALIA; HEXAPODA; INVERTEBRATA; MAMMALIA;

ANIMALS; BODY WEIGHT; HUMANS; HYPOTENSION; MOLECULAR STRUCTURE; OCTOPAMINE; PROTEIN BINDING; RECEPTORS, BIOGENIC AMINE; STEREOISOMERISM;

EID: 84925247981     PISSN: 01480545     EISSN: 15256014     Source Type: Journal    
DOI: 10.3109/01480545.2014.900069     Document Type: Review

References (69)

1. Alemzadeh R, Karlstad MD, Tushaus K, Buchholz M. (2008). Diazoxide enhances basal metabolic rate and fat oxidation in obese Zucker rats. Metabolism 57:1597-1607.
2. Arch JRS. (2002). β3-adrenoceptor agonists: potential, pitfalls and progress. Eur J Pharmacol 440:99-107.
3. Avula B, Upparapalli SK, Navarrete A. (2005). Simultaneous quantification of adrenergic amines and flavonoids in C. aurantium, various Citrus species, and dietary supplements by liquid chromatography. J AOAC Int 88:1593-1606.
4. Axelrod J, Saavedra JM. (1977). Octopamine. Nature 265:501-504.
5. Blais V, Bounif N, Dubé F. (2010). Characterization of a novel octopamine receptor expressed in the surf clam Spisula solidissima. Gen Compar Endocrinol 167:215-227.
6. Borowsky B, Adham, N, Jones KA, et al. (2001). Trace amines: identification of a family of mammalian G protein-coupled receptors. Proc Natl Soc Sci USA 98:8966-8971.
7. Bour S, Visentin V, Prevot D, Carpene C. (2003). Moderate weight-lowering effect of octopamine treatment in obese Zucker rats. J Physiol Biochem 59:175-182.
8. Braasch W, Buchhold J, Kohler C. (1971). Zur Therapie orthostatischer Regularionsstorungen. Deutsche Med Wochenschrift 40:1557-1562.
9. Brandau K, Axelrod J. (1972). The biosynthesis of octopamine. Naunyn Schmiedeberg's Arch Pharmacol 273:123-133.
10. Brown CM, McGrath JC, Midgley JM, et al. (1988). Activities of octopamine and synephrine stereoisomers on a-adrenoreceptors. Br J Pharmacol 93:417-429.
11. Bunzow JR, Sonders MS, Arttamangku S, et al. (2001). Amphetamine, 3, 4-methylenedioxyamphetamine, lysergic acid diethylamide, and metabolites of the catecholamine neurotransmitters are agonists of the rat trace amine receptor. Mol Pharmacol 60:1181-1188.
12. Burchett SA, Hicks TP. (2006). The mysterious trace amines: protean neuromodulators of synaptic transmission in mammalian brain. Prog Neurobiol 79:223-246.
13. Carpene C, Galitzky J, Fontana E, et al. (1999). Selective activation of beta 3-adrenoreceptors by octopamine: comparative studies in mammalian fat cells. Naunyn Schmiedeberg's Arch Pharmacol 359: 310-321.
14. Chance WT, Bernardini AP, James JH, et al. (1985). Behavioral depression after intraventricular infusion of octopamine in rats. Am J Surg 150:577-584.
15. D'Andrea G, D'Arrigo A, Carbonare MD, Leon A. (2012a). Pathogenesis of migraine: role of neuromodulators. Headache 52:1155-1163.
16. D'Andrea G, Nordera G, Pizzolato G, et al. (2012b). Trace amine metabolism in Parkinson's disease: low circulating levels of octopamine in early disease stages. Neurosci Lett 469:348-351.
17. D'Andrea G, D'Amico D, Bussone G, et al. (2013). The role of tyrosine metabolism in the pathogenesis of chronic migraine. Cephalalgia 33:932-937.
18. D'Andrea G, Ostuzzi R, Francesconi F, et al. (2009). Migraine prevalence in eating disorders and pathophysiological correlations. Neurol Sci 30:555-559.
19. David JC, Coulon JF, Cavoy A, Delacour J. (1989). Effects of aging on p- and m-octopamine, catecholamines, and their metabolizing enzymes in the rat. J Neurochem 53:149-154.
20. Delacour J, Guenaire C. (1983). Octopamine and locomotor activity of rats. Psychopharmacol 80:50-52.
21. de Oliveira AL, de Paula MN, Comar JF, et al. (2013). Adrenergic metabolic and hemodynamic effects of octopamine in the liver. Int J Mol Sci 14:218858-21872.
22. Erspamer V. (1948). Active substances in the posterior salivary glands of Octopoda. 2. Tyramine and octopamine (oxyoctopamine). Acta Pharmacol Toxicol 4:224-247.
23. Evans PD, Maqueira B. (2005). Insect octopamine receptors: a new classification scheme based on studies of cloned Drosophila G-protein coupled receptors. Invertebrate Neurosci 5:111-118.
24. Evans PD, Thonoor CM, Midgley JM. (1988). Activities of octopamine and synephrine stereoisomers on octopaminergic receptor subtypes in locust skeletal muscle. J Pharm Pharmacol 40:855-861.
25. Farooqui T. (2007). Octopamine-mediated neuromodulation of insect senses. Neurochem Res 32:1511-1529.
26. Fegly MJ, Kelleher DL, Williams CM. (1979). Adrenergic activity of ortho-, meta-, and para-octopamine. Pharmacology 18:180-187.
27. Ghiretti F. (1953). Enteramine, octopamine, and tyramine in external and internal secretion of the posterior salivary gland in octopus. Arch Sci Biol 37:435-441.
28. Gosetti F, Mazzucco, E, Gennaro MC, Marengo E. (2013). Simultaneous determination of sixteen underivatized biogenic amines in human urine by HPLC-MS/MS. Anal Bioanal Chem 405:907-916.
29. Hamilton BS, Doods HN. (2008). Identification of potent agonists acting at an endogenous atypical β3-adrenoceptor state that modulate lipolysis in rodent fat cells. Eur J Pharmacol 580:55-62.
30. Hengstmann JH, Konen W, Konen C, et al. (1974). The physiological disposition of p-octopamine in man. Naunyn Schmiedeberg's Arch Pharmacol 283:93-106.
31. Hoff M, Balfanz S, Ehling P, Baumann A. (2011). A single amino acid residue controls Ca2+ signaling by an octopamine receptor from Drosophila melanogaster. FASEB J 25:2484-2491.
32. Hortnagl H, Lochs H, Kleinberger G, et al. (1981). Plasma catecholamines in hepatic coma and liver cirrhosis: role of octopamine. Klin Wochenschr 59:1159-1164.
33. Ibrahim KE, Couch MW, Williams CM, et al. (1985). m-Octopamine: normal occurrence with p-octopamine in mammalian sympathetic nerves. Neurochem 44:1862-1867.
34. Inchiosa Jr MA. (2011). Evidence (mostly negative) with the use of sympathomimetic agents for weight loss. J Obesity 2011: Article ID 764584, 4 pages.
35. Ishida Y, Ozaki M. (2011). A putitive octopamine/tyramine receptor mediating appetite in a hungry fly. Naturwissenschaften 98:635-638.
36. Klaassen LW, Kammer AE. (1985). Octopamine enhances neuromuscular transmission in developing and adult moths, Manduca sexta. J Neurobiol 16:227-243.
37. Kraupp O, Bernheimer H, Heistracher P, et al. (1961). 1-(4- Hydroxyphenyl)-2-methylaminoathenol (Sympatol) im Harn eines Falls mit Hochdruck. Wien Klin Wachr 73:712-716.
38. Kuske FA. (1969). Zur Behandlung hypotoner Regulationsstorungen mit Norphen. Ther Gegenwart 108:1460-1462.
39. Lind U, Alm RM, Hasselberg FL, et al. (2010). Octopamine receptors from the barnacle Balanus improvisus are activated by the α2-adrenoceptor agonist medetomidine. Mol Pharmacol 78:237-248.
40. Lindemann L, Eberling M, Kratochwil NA, et al. (2005). Trace amine associated receptors form structurally and functionally distinct subfamilies of novel G protein-coupled receptors. Genomics 85: 372-385.
41. Medana C, Calza P, Gaincotti V, et al. (2013). Study of the photocatalytic transformation of synephrine: a biogenic amine relevant in antidoping analysis. Anal Bioanal Chem 405:1105-1113.
42. Mestrovic N. (1972). Über die Behandlung hypotoner Zustande bei chirugischen Patienten. Zeitschrift Allgemeinmed 48:1301-1303.
43. Mousseau DD, Butterworth RF. (1995). Trace amines in hepatic encephalopathy. Prog Brain Res 106:277-284.
44. Nakano J, Ishii T, Cole B, Oliver R. (1969). Effect of tyramine and octopamine on lipolysis in isolated fat cells of the rat. J Pharm Pharmacol 21:620-622.
45. Nelson BC, Putzbach K, Sharpless KE, Sander LC. (2007). Mass spectrometric determination of the predominant adrenergic protoalkaloids in bitter orange (Citrus aurantium). Agric Food Chem 55: 9769-9775.
46. Nishi Y, Sasaki K, Miyatake T. (2010). Biogenic amines, caffeine and tonic immobility in Tribolium castaneum. J Insect Physiol 56: 622-628.
47. Oana F, Homma T, Takeda H, et al. (2005). DNA microarray analysis of white adipose tissue from obese (fa/fa) Zucker rats treated with a β3-adrenoceptor agonist, KTO-7924. Pharmacol Res 52:395-400.
48. Park JH, Keeley LL. (1998). The effect of biogenic amines and their analogs on carbohydrate metabolism in the fat body of the cockroach Blaberus discoidalis. Gen Compar Endocrinol 110:88-95.
49. Pellati F, Benvenuti S. (2007a). Chromatographic and electrophoretic methods for the analysis of phenethylamine alkaloids in Citrus aurantium. J Chromatogr A 1171:71-88.
50. Pellati F, Benvenuti S. (2007b). Fast high-preformance liquid chromatography analysis of phenethylamine alkaloids in Citrus natural products on a pentafluorophenylpropyl stationary phase. J Chromatog A 1165:58-66.
51. Rahmani MA, Cheema IR, Sen S, Peoples B. (1987). Evaluation of isomers of octopamine for in vitro alpha-adrenergic stimulation of the aortic smooth muscle from spontaneously hypertensive rats. Cytobios 52:7-16.
52. Ress RJ, Rahmani MJ, Field FP, Williams CM. (1980). Effect of isomers of octopamine on in vitro reactivity of vascular smooth muscle of rats. Pharmacology 21:342-347.
53. Reyes-Colon D, Vasquez-Acevedo N, Rivera NM, et al. (2010). Cloning and distribution of a putative octopamine/tyramine receptor in the central nervous system of the freshwater prawn Macrobrachium rosenbergii. Brain Res 1348:42-54.
54. Rillich J, Schildberger K, Stevenson PA. (2011). Octopamine and occupancy: an aminergic mechanism for intruder resident aggression in crickets. Proceed Biol Sci 278:1873-1880.
55. Sander LC, Putzbach K, Nelson RC, et al. (2008). Certification of standard reference materials containing bitter orange. Anal Bioanal Chem 391:2023-2034.
56. Sandler M, Ruthven CRJ, Goodwin BL, et al. (1979). Deficit production of tyramine and octopamine in cases of depression. Nature 278: 357-358.
57. Scoop News (2011). WADA lab clears Thermotone. Available from: http://www.scoop.co.nz/stories/CU1109/800356/wada-lab-clears-thermotone. htm. Accessed September 3, 2013.
58. Sinakevitch I, Mustard JA, Smith BH. (2011). Distribution of the octopamine receptor AmOA1 in the honey bee brain. PLoS One 6: e14536.
59. Stohs SJ, Preuss HG, Shara M. (2011). A review of the receptor-binding properties of p-synephrine as related to its pharmacological effects. Oxid Med Cell Long 2011: Article ID 482973, 9 pages.
60. Stucke W. (1972). Die Behandlung hypotoner Kreislaufstorungen mit Norphen retard. Z Allgemeinmed 48:240-243.
61. Thevis M, Koch A, Sigmund G, et al. (2012). Analysis of octopamine in human doping control samples. Biomed Chromatog 26:610-615.
62. Thum HJ. (1967). Klinische Untersuchung eines neuen Syphathikomometicums. Arzneimittelforsch 17:1449-1451.
63. Torkkeli PH, Panek I, Meisner S. (2011). Ca2+ calmodulin-dependent protein kinase II mediates the octopamine-induced increase in sensitivity in spider VS-3 mechanosensory neurons. Eur J Neurosci 33:1186-1196.
64. Uckoo RM, Jayaprakasha GK, Nelson SD, Patil BS. (2011). Rapid simultaneous determination of amines and organic acids in citrus using high-performance liquid chromatography. Talanta 83:948-954.
65. World Anti-Doping Agency (WADA). (2014). The 2014 prohibited list international standard. Available from: www.wada-ama.org/ Documents/World-Anti-Doping-Program/WADP-Prohibited-list/ 2014/WADA-Prohibited-List-2014-EN.pdf. Accessed January 27, 2014.
66. Wu SF, Yao Y, Huang J, Ye GY. (2012). Characterization of a β-adrenergic-like receptor from the rice stem borer (Chilo suppressalis). J Exp Biol 215:2646-2652.
67. Yen ST, Li MH, Hsu CT, et al. (1998). Stimulatory effect of octopamine on beta 3-adrenoreceptors to lower the uptake of [14C]-deoxy-Dglucose into rat adipocytes in vitro. J Auton Pharmacol 18:13-19.
68. Ziegelmayer W. (1972). Erfahrungen aus der praxis über die Behandlung des Blutunterdruckes mit Norphen. Med Welt 23:1721-1722.
69. Zucchi R, Chiellini G, Scanlan TS, Grandy DK. (2006). Trace amine-associated receptors and their ligands. Br J Pharmacol 149: 967-978.